Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Randomised, Placebo Controlled, Two Period Cross-Over Study to Evaluate the Efficacy and Safety of Orvepitant in Chronic Cough in Patients With Idiopathic Pulmonary Fibrosis

NCT05185089 is registered in ClinicalTrials.gov with Nerre Therapeutics Ltd. as lead sponsor.

NCT NCT05185089
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05185089 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Randomised, Placebo Controlled, Two Period Cross-Over Study to Evaluate the Efficacy and Safety of Orvepitant in Chronic Cough in Patients With Idiopathic Pulmonary Fibrosis
Lead sponsor
Nerre Therapeutics Ltd.
Phase
Phase 2
Overall status
Completed
Start date
August 1, 2022
Completion date
June 19, 2024
Enrollment
80 (actual)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

cough, idiopathic pulmonary fibrosis